Jon Halbert bought $990K of Caris Life Sciences (CAI)
Executed May 15, disclosed Jul 13, 59 days later, against a two-business-day limit.
Over the 21 trading sessions from the disclosed entry session (Jul 13), the stock returned +36.8% (delay-adjusted); from the execution session (May 15), +19.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
Jon Halbert (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales, 1 filed past the two-business-day deadline), most often in Caris Life Sciences, Inc. (CAI). Across 1 priced purchase filing, the average 21-session return was +19.2% from execution and +36.8% from disclosure (delay-adjusted; derived). The largest single filing was $990K of CAI (68,000 sh × $14.56, as filed), executed May 15.
Healthcare · Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and inter…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→